Guidance Adherent Dabigatran Etexilate Treatment Versus Warfarin in the Re-Ly Population: an Analysis on the Basis of the European Label Recommendations for Dabigatran Etexilate
                        AuthID
P-006-K17
                
    P-006-K17
 
    
                    